• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性丙型肝炎治疗失败后患者病毒清除延迟。

Delayed viral clearance of chronic hepatitis C in patients after treatment failure.

机构信息

Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.

出版信息

Gut Liver. 2011 Mar;5(1):110-4. doi: 10.5009/gnl.2011.5.1.110. Epub 2011 Mar 16.

DOI:10.5009/gnl.2011.5.1.110
PMID:21461084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3065086/
Abstract

Hepatitis C virus (HCV) infection usually progresses to chronic hepatitis, with rare cases of spontaneous viral eradication. We present herein four cases involving patients that were initially declared to have failed to respond to treatments, based on the presence of HCV RNA that was still detectable after completion of the standard treatment for chronic hepatitis C with genotype 2. However, the HCV RNA became undetectable, with a delayed response, after discontinuation of therapy. Two of the four patients were diagnosed as treatment failures after extended treatment, and the other two received no further treatment after the standard treatment. All four patients maintained a sustained virological response during the periodic follow-up after delayed viral clearance.

摘要

丙型肝炎病毒(HCV)感染通常会进展为慢性肝炎,极少数情况下会自发清除病毒。我们在此介绍 4 例患者,这些患者最初被诊断为对治疗无应答,原因是在完成慢性丙型肝炎基因型 2 的标准治疗后,仍可检测到 HCV RNA。然而,在停止治疗后,HCV RNA 出现延迟应答而转为不可检测。这 4 例患者中的 2 例在延长治疗后被诊断为治疗失败,另外 2 例在标准治疗后未再接受进一步治疗。所有 4 例患者在延迟病毒清除后的定期随访中均保持持续病毒学应答。

相似文献

1
Delayed viral clearance of chronic hepatitis C in patients after treatment failure.慢性丙型肝炎治疗失败后患者病毒清除延迟。
Gut Liver. 2011 Mar;5(1):110-4. doi: 10.5009/gnl.2011.5.1.110. Epub 2011 Mar 16.
2
Re-treatment of patients with hepatitis C who failed to respond (nonresponders) to previous treatment.对先前治疗无反应(无反应者)的丙型肝炎患者进行再治疗。
Georgian Med News. 2009 Jan(166):61-4.
3
Interferon lambda 3 rs12979860 polymorphism in patients with haemophilia and HCV infection: a predictor of spontaneous viral clearance and sustained virological response.血友病合并丙型肝炎病毒感染患者中干扰素λ3 rs12979860多态性:自发病毒清除和持续病毒学应答的预测指标
Thromb Haemost. 2014 Jun;111(6):1067-76. doi: 10.1160/TH13-11-897. Epub 2014 Feb 13.
4
Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients.对于慢性丙型肝炎基因1型感染的低反应成年患者,长效聚乙二醇干扰素联合利巴韦林治疗72周与标准聚乙二醇干扰素联合利巴韦林治疗48周的对比研究。
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD008516. doi: 10.1002/14651858.CD008516.pub2.
5
Viral clearance or persistence after acute hepatitis C infection: interim results from a prospective study.急性丙型肝炎感染后的病毒清除或持续存在:一项前瞻性研究的中期结果
Medicina (Kaunas). 2008;44(7):510-20.
6
Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre study.α干扰素诱导疗法对2b/3a基因型及低病毒载量丙型肝炎病毒感染的影响。一项随机多中心研究。
Scand J Gastroenterol. 2002 Mar;37(3):344-9. doi: 10.1080/003655202317284264.
7
Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.慢性丙型肝炎患者接受干扰素治疗后丙型肝炎病毒的完全清除。
Ital J Gastroenterol Hepatol. 1997 Jun;29(3):255-61.
8
Rapid virological response assessment by Abbott RealTime hepatitis C virus assay for predicting sustained virological responses in patients with hepatitis C virus genotype 1 treated with pegylated-interferon and ribavirin.采用雅培实时丙型肝炎病毒检测法进行快速病毒学反应评估,以预测接受聚乙二醇干扰素和利巴韦林治疗的丙型肝炎病毒1型患者的持续病毒学反应。
Kaohsiung J Med Sci. 2016 Jul;32(7):381-6. doi: 10.1016/j.kjms.2016.06.002. Epub 2016 Jun 27.
9
[A real-world study of sofosbuvir-based drug treatment for hepatitis C virus genotype 6 infection in Hainan region of China].[中国海南地区基于索磷布韦的药物治疗丙型肝炎病毒6型感染的真实世界研究]
Zhonghua Gan Zang Bing Za Zhi. 2021 Jul 20;29(7):679-684. doi: 10.3760/cma.j.cn501113-20200525-00271.
10
Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection.急性丙型肝炎感染自发病毒清除的预测因素及转归
Clin Mol Hepatol. 2014 Dec;20(4):368-75. doi: 10.3350/cmh.2014.20.4.368. Epub 2014 Dec 24.

引用本文的文献

1
Modeling how reversal of immune exhaustion elicits cure of chronic hepatitis C after the end of treatment with direct-acting antiviral agents.模拟直接作用抗病毒药物治疗结束后免疫衰竭逆转如何引发慢性丙型肝炎的治愈。
Immunol Cell Biol. 2018 Oct;96(9):969-980. doi: 10.1111/imcb.12161. Epub 2018 Jun 5.
2
Delayed Viral Clearance after 6-Week Treatment with Peginterferon Plus Ribavirin in a Patient with Chronic Hepatitis C Virus Genotype 1b.慢性丙型肝炎病毒1b型患者接受聚乙二醇干扰素加利巴韦林治疗6周后病毒清除延迟
Case Rep Gastroenterol. 2016 Aug 9;10(2):417-422. doi: 10.1159/000448072. eCollection 2016 May-Aug.

本文引用的文献

1
Thymosin Alpha-1 in Combination with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients Who have Failed to Prior Pegylated Interferon and Ribavirin Treatment.胸腺法新α-1 联合聚乙二醇干扰素和利巴韦林治疗对既往聚乙二醇干扰素和利巴韦林治疗无应答的慢性丙型肝炎患者。
Gut Liver. 2007 Jun;1(1):87-9. doi: 10.5009/gnl.2007.1.1.87. Epub 2007 Jun 30.
2
Persistent transaminase elevations in chronic hepatitis C patients with virological response during peginterferon and ribavirin therapy.接受聚乙二醇干扰素和利巴韦林治疗期间出现病毒学应答的慢性丙型肝炎患者转氨酶持续升高。
Hepatogastroenterology. 2009 May-Jun;56(91-92):798-801.
3
Treatment of chronic hepatitis C in a slow responder: a case for extended therapy.慢反应者慢性丙型肝炎的治疗:延长治疗的一个实例
Nat Rev Gastroenterol Hepatol. 2009 Jun;6(6):372-5. doi: 10.1038/nrgastro.2009.65.
4
Diagnosis, management, and treatment of hepatitis C: an update.丙型肝炎的诊断、管理与治疗:最新进展
Hepatology. 2009 Apr;49(4):1335-74. doi: 10.1002/hep.22759.
5
Optimizing outcomes in patients with hepatitis C virus genotype 2 or 3.优化丙型肝炎病毒2型或3型患者的治疗效果。
Antivir Ther. 2008;13 Suppl 1:17-22.
6
Studies of therapy with thymosin alpha1 in combination with pegylated interferon alpha2a and ribavirin in nonresponder patients with chronic hepatitis C.α1胸腺素联合聚乙二醇化α2a干扰素和利巴韦林治疗慢性丙型肝炎无反应患者的研究
Ann N Y Acad Sci. 2007 Sep;1112:368-74. doi: 10.1196/annals.1415.047. Epub 2007 Jun 28.
7
Chronic hepatitis C: viral clearance several months after discontinuation of therapy in two non-responders.慢性丙型肝炎:两名无反应者在停止治疗数月后病毒清除
Infection. 2007 Jun;35(3):197-200. doi: 10.1007/s15010-007-6099-7.
8
A 5-year prospective study of the late resolution of chronic hepatitis C after antiviral therapy.一项关于抗病毒治疗后慢性丙型肝炎延迟缓解的5年前瞻性研究。
Aliment Pharmacol Ther. 2007 May 1;25(9):1039-46. doi: 10.1111/j.1365-2036.2007.03295.x.
9
Pegylated interferon and ribavirin failures: is retreatment an option?聚乙二醇干扰素和利巴韦林治疗失败:再次治疗是一种选择吗?
Dig Dis Sci. 2007 Mar;52(3):732-6. doi: 10.1007/s10620-006-9457-x.
10
Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.慢性丙型肝炎患者接受聚乙二醇干扰素α-2b联合利巴韦林治疗后的早期病毒学反应
Hepatology. 2003 Sep;38(3):645-52. doi: 10.1053/jhep.2003.50364.